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Background
Lithium has largely met its initial promise as the first drug
to be discovered in the modern era of psychopharmacol-
ogy, yet no definitive mechanism for its effect has been
established. In the present study we evaluated the involve-
ment of L-arginine/nitric oxide (NO)/cGMP pathway in
the antidepressant-like effects of acute lithium adminis-
tration in the mouse forced swimming test (FST).
Materials and methods
Male NMRI mice weighting 23-30 g (Pasteur Institute)
were used throughout the study. The FST was conducted
using the method of Porsolt [1]. The locomotor activity
was also evaluated by an open-field test.
Results
Lithium, at 30 and 100 mg/kg, significantly reduced the
immobility times of mice in the FST, whereas at lower
doses (0.5, 5 and 10 mg/kg) had no effect on the immo-
bility time. The NO synthase (NOS) inhibitor NG-nitro-L-
arginine methyl ester (L-NAME), at 10 and 30 mg/kg, and
the selective neuronal NOS inhibitor Nω-propyl-L-
arginine (L-NPA), at 5 and 15 mg/kg, had no significant
effects on the FST, whereas they significantly decreased the
immobility time at 100 and 30 mg/kg, respectively. Com-
bination of non-effective dose of lithium (10 mg/kg) with
low doses of L-NAME (30 mg/kg) or L-NPA (15 mg/kg)
significantly reduced the immobility times in the FST.
Moreover, the guanylyl cyclase inhibitor ODQ at 50 mg/
kg significantly decreased the immobility time of mice,
whereas it had not significant effects on the FST at 2, 10
and 20 mg/kg. Combination of lithium (10 mg/kg) with
20 mg/kg ODQ significantly decreased the immobility
times in the FST. Non-effective doses of L-arginine (750
mg/kg) or sildenafil (5 mg/kg) significantly reversed the
antidepressant-like effect of 30 mg/kg lithium in the FST.
Neither of the drugs had effect on the locomotor activity.
Conclusions
These data indicate the involvement of L-arginine/NO/
cGMP pathway in the antidepressant-like effect of lithium
in the mouse FST and also might suggest the concurrent
administration of NOS inhibitors and lithium as an
appropriate strategy for treatment of depression.
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